Close
MIDAS
Eva Enns
Eva_Enns
Twitter Linkedin Github Academicicon-GoogleScholar Academicicon-Orcid1 Envelope

Associate Professor

Education

Affiliations

Division of Health Policy and Management, School of Public Health, University of Minnesota

Projects

Papers

Rao DW, Wheatley MM, Goodreau SM, Enns EA. (2021). Partnership dynamics in mathematical models and implications for representation of sexually transmitted infections: a review. Annals of epidemiology

Siriruchatanon M, Liu S, Carlucci JG, Enns EA, Duarte HA. (2021). Addressing Pediatric HIV Pretreatment Drug Resistance and Virologic Failure in Sub-Saharan Africa: A Cost-Effectiveness Analysis of Diagnostic-Based Strategies in Children ≥3 Years Old. Diagnostics (Basel, Switzerland), 11(3)

Quan AML, Mah C, Krebs E, Zang X, Chen S, Althoff K, Armstrong W, Behrends CN, Dombrowski JC, Enns E, Feaster DJ, Gebo KA, Goedel WC, Golden M, Marshall BDL, Mehta SH, Pandya A, Schackman BR, Strathdee SA, Sullivan P, Tookes H, Nosyk B, . (2021). Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities. The lancet. HIV

Jenness SM, Knowlton G, Smith DK, Marcus JL, Anderson EJ, Siegler AJ, Jones J, Sullivan PS, Enns E. (2021). A decision analytics model to optimize investment in interventions targeting the HIV PrEP cascade of care. AIDS (London, England)

Krijkamp EM, Alarid-Escudero F, Enns EA, Pechlivanoglou P, Hunink MGM, Yang A, Jalal HJ. (2020). A Multidimensional Array Representation of State-Transition Model Dynamics. Medical decision making : an international journal of the Society for Medical Decision Making

Kao SZ, Enns EA. (2020). Follow the Sex: Influence of Network Structure on the Effectiveness and Cost-Effectiveness of Partner Management Strategies for Sexually Transmitted Infection Control. Sexually transmitted diseases, 47(2)

Duarte HA, Babigumira JB, Enns EA, Stauffer DC, Shafer RW, Beck IA, Garrison LP Jr., Chung MH, Frenkel LM, Bendavid E. (2020). Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women. EClinicalMedicine, (22)

Alarid-Escudero F, Krijkamp EM, Pechlivanoglou P, Jalal H, Kao SZ, Yang A, Enns EA. (2019). A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling. PharmacoEconomics, 37(11)

Enns EA, Reilly CS, Horvath KJ, Baker-James K, Henry K. (2019). HIV Care Trajectories as a Novel Longitudinal Assessment of Retention in Care. AIDS and behavior, 23(9)

Chehrazi N, Cipriano LE, Enns EA. (2019). Dynamics of Drug Resistance: Optimal Control of an Infectious Disease. Operations research, 67(3)

Alarid-Escudero F, Enns EA, Kuntz KM, Michaud TL, Jalal H. (2019). "Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 22(5)

Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MGM, Pechlivanoglou P. (2018). Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial. Medical decision making : an international journal of the Society for Medical Decision Making, 38(3)

Alarid-Escudero F, MacLehose RF, Peralta Y, Kuntz KM, Enns EA. (2018). Nonidentifiability in Model Calibration and Implications for Medical Decision Making. Medical decision making : an international journal of the Society for Medical Decision Making, 38(7)

Kao SZ, VanderWaal K, Enns EA, Craft ME, Alvarez J, Picasso C, Wells SJ. (2018). Modeling cost-effectiveness of risk-based bovine tuberculosis surveillance in Minnesota. Preventive veterinary medicine, (159)

Lee K, Drekonja DM, Enns EA. (2018). Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 21(3)

VanderWaal K, Enns EA, Picasso C, Alvarez J, Perez A, Fernandez F, Gil A, Craft M, Wells S. (2017). Optimal surveillance strategies for bovine tuberculosis in a low-prevalence country. Scientific reports, 7(1)

Enns EA, Kao SY, Kozhimannil KB, Kahn J, Farris J, Kulasingam SL. (2017). Using Multiple Outcomes of Sexual Behavior to Provide Insights Into Chlamydia Transmission and the Effectiveness of Prevention Interventions in Adolescents. Sexually transmitted diseases, 44(10)

Enns EA, Reilly CS, Virnig BA, Baker K, Vogenthaler N, Henry K. (2016). Potential Impact of Integrating HIV Surveillance and Clinic Data on Retention-in-Care Estimates and Re-Engagement Efforts. AIDS patient care and STDs, 30(9)

Enns EA, Brandeau ML. (2015). Link removal for the control of stochastically evolving epidemics over networks: a comparison of approaches. Journal of theoretical biology, (371)

Enns EA, Zaric GS, Strike CJ, Jairam JA, Kolla G, Bayoumi AM. (2016). Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada. Addiction (Abingdon, England), 111(3)

Enns EA, Cipriano LE, Simons CT, Kong CY. (2015). Identifying best-fitting inputs in health-economic model calibration: a Pareto frontier approach. Medical decision making : an international journal of the Society for Medical Decision Making, 35(2)

Enns EA, Mounzer JJ, Brandeau ML. (2012). Optimal link removal for epidemic mitigation: a two-way partitioning approach. Mathematical biosciences, 235(2)

Enns EA, Brandeau ML. (2011). Inferring model parameters in network-based disease simulation. Health care management science, 14(2)

Enns EA, Brandeau ML, Igeme TK, Bendavid E. (2011). Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention. International journal of STD & AIDS, 22(10)

If you’d like to update your profile, please email modifications to questions@midasnetwork.us.

MIDAS

Navigation
Learn More
Resources

MIDAS Coordination Center

Contact us: questions@midasnetwork.us

Thank you to NIGMS Grant U24GM132013 for supporting the work at the Coordination Center.

Copyright MIDAS © 2022. All Rights Reserved.

This site is registered on wpml.org as a development site.